BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17409025)

  • 1. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.
    Gomer B; Wagner K; Frings L; Saar J; Carius A; Härle M; Steinhoff BJ; Schulze-Bonhage A
    Epilepsy Behav; 2007 May; 10(3):486-94. PubMed ID: 17409025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.
    Fritz N; Glogau S; Hoffmann J; Rademacher M; Elger CE; Helmstaedter C
    Epilepsy Behav; 2005 May; 6(3):373-81. PubMed ID: 15820346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice.
    Bootsma HP; Aldenkamp AP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsia; 2006; 47 Suppl 2():24-7. PubMed ID: 17105455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.
    Huang CW; Pai MC; Tsai JJ
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):548-53. PubMed ID: 18950374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.
    Cho JR; Koo DL; Joo EY; Yoon SM; Ju E; Lee J; Kim DY; Hong SB
    Clin Neurophysiol; 2012 May; 123(5):883-91. PubMed ID: 22000706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive profile of topiramate as compared with lamotrigine in epilepsy patients on antiepileptic drug polytherapy: relationships to blood serum levels and comedication.
    Kockelmann E; Elger CE; Helmstaedter C
    Epilepsy Behav; 2004 Oct; 5(5):716-21. PubMed ID: 15380124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
    Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
    Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study.
    Ciesielski AS; Samson S; Steinhoff BJ
    Epilepsy Behav; 2006 Nov; 9(3):424-31. PubMed ID: 16949344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
    Kim DW; Lee SY; Shon YM; Kim JH
    Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.
    Mula M; Trimble MR; Sander JW
    Epilepsia; 2007 Dec; 48(12):2322-6. PubMed ID: 17711462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.
    Lee HW; Jung DK; Suh CK; Kwon SH; Park SP
    Epilepsy Behav; 2006 Jun; 8(4):736-41. PubMed ID: 16647301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients.
    Koo DL; Hwang KJ; Kim D; Kim YJ; Kim JY; Shin W; Kim MR; Joo EY; Lee JM; Hong SB
    Eur Neurol; 2013; 70(1-2):88-94. PubMed ID: 23839084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam.
    Roberts GM; Majoie HJ; Leenen LA; Bootsma HP; Kessels AG; Aldenkamp AP; Leonard BE
    Epilepsy Behav; 2005 May; 6(3):366-72. PubMed ID: 15820345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
    López-Góngora M; Martínez-Domeño A; García C; Escartín A
    Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topiramate and zonisamide on fMRI cognitive networks.
    Wandschneider B; Burdett J; Townsend L; Hill A; Thompson PJ; Duncan JS; Koepp MJ
    Neurology; 2017 Mar; 88(12):1165-1171. PubMed ID: 28213372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of levetiracetam on μ rhythm in persons with epilepsy.
    Lin CC; Ju MS; Chen CW; Hwang JC; Tsai JJ
    J Clin Neurosci; 2013 May; 20(5):686-91. PubMed ID: 23517673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive adverse events of topiramate in patients with epilepsy and intellectual disability.
    Brandt C; Lahr D; May TW
    Epilepsy Behav; 2015 Apr; 45():261-4. PubMed ID: 25843340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.